{
    "pmcid": "9201380",
    "qa_pairs": {
        "From which animal was the nanobody DL28 derived after immunization with the RBD of the SARS-CoV-2 spike protein?": [
            "Alpaca",
            "Llama",
            "Camel",
            "Horse"
        ],
        "What is the dissociation constant (KD) of the nanobody DL28 when binding to the RBD of the SARS-CoV-2 spike protein?": [
            "1.56 nM",
            "0.56 nM",
            "2.56 nM",
            "1.05 nM"
        ],
        "What is the primary advantage of nanobodies like DL28 for therapeutic development?": [
            "Small size and stability",
            "High molecular weight",
            "Complex glycosylation",
            "Long half-life in circulation"
        ],
        "What specific region of the RBD does DL28 binding alter to prevent ACE2 engagement?": [
            "Backrest region",
            "Frontline region",
            "Core region",
            "Lateral region"
        ],
        "Which unique mechanism does the nanobody DL28 employ to neutralize SARS-CoV-2 variants?": [
            "Conformation competition",
            "Direct competition",
            "Steric hindrance",
            "Receptor blockade"
        ]
    }
}